A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM
Clinical trial NCT05680129 · COMPLETED
Trial details
- NCT number
- NCT05680129
- Sponsor
- Hangzhou Sciwind Biosciences Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-10
- Primary completion
- 2024-07-03
- Enrollment
- 623
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.